2 completed, 1 active not recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Active not recruiting 1 |
Follow Currax Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) Naltrexone-Bupropion (NB) Combination, Placebo - Obesity | Phase 4 | Active not recruiting | Currax Pharmaceuticals | 8600 | 2024-01-03 | 2026-03-31 |
| Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers Silenor 6 mg, zolpidem 10 mg, Placebo - Healthy | Phase 4 | Completed | Currax Pharmaceuticals | 52 | 2015-01-01 | 2018-01-02 |
| Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response? Triptan, Treximet 85Mg-500Mg Tablet - Workplace Migraine Treatment | Phase 4 | Completed | The Cleveland Clinic | 60 | 2009-09-01 | 2018-05-01 |
Migraine Disorders (1) · Obesity (1)
Doxepin (1) · Naproxen (1) · Sumatriptan (1) · Tryptamines (1) · Zolpidem (1) · sumatriptan-naproxen (1)
United States (3)
Chris Drake, PhD (1) · Jennifer S Kriegler, MD (1)